Who Owns the Innovation? IP Strategy in a Transatlantic Company
International growth often separates the company that raises the money from the company that creates the technology. A U.S. parent may raise capital and sign customer contracts, while, for example, an Israeli subsidiary employs the engineers conducting R&D and a European affiliate handles distribution. Sometimes this structure is designed in advance; other times it takes shape as the company follows talent, customers, funding and other opportunities. In either case, the company eventually must address a deceptively simple issue: who owns the innovation and, related, whether other entities have the rights they need to use it.
For many emerging companies, the intellectual property (IP) protecting that innovation is the crown jewel. Yet a parent owns the shares of its subsidiary; it does not thereby own the subsidiary’s assets. Forming a U.S. affiliate, moving personnel or completing a share-for-share flip does not, by itself, transfer technology and related IP from one entity to another. If the corporate and IP structures drift apart, the result can affect valuation, delay a financing, or leave the investor-backed company dependent on rights it does not securely control. However, moving IP between jurisdictions can often result in other issues, such as tax falling due. So what do founders need to be aware of?
The analysis may begin with corporate structure, but it does not end there. The company must align the entities that raise capital, employ the people creating the technology, commercialize it, and own or license the resulting IP. The objective is not to force every international company into the same model. It is to make legal title, operating rights and investor control fit the way the company and its affiliates actually conduct business.
Corporate Structure May Be Planned—or Evolve Organically
When a structure can be planned from the outset, the company can designate the intended IP owner, define the R&D and commercialization roles of each affiliate, and put the necessary assignments and licenses in place before substantial value accumulates. Other structures develop organically. A company may add subsidiaries, move engineers, enter new markets or change which entity contracts with customers. Each change may affect who creates, owns or needs to use the IP. A subsidiary may need a broader license from its parent, a parent may need rights from its subsidiary, or an existing agreement may no longer match the affiliates’ actual roles.
The corporate chart is not a substitute for chain of title. Placing a Delaware parent at the top of the group structure doesn’t make it the owner of IP created by employees of a foreign subsidiary. Those rights must be connected through contributor agreements, assignments, licenses and intercompany arrangements.
As we have previously explained in Startup IP Myths That Can Cost You Millions (or Kill Your Exit), paying a developer does not necessarily mean the company owns the resulting work. The same applies under English law. If the developer is an employee, the invention belongs to the employer where it is made in the course of the employee’s normal duties. Contractors are different: The creator is generally the first owner of relevant rights unless there is an assignment. Founders, employees and contractors may also be subject to obligations owed to former employers, universities or other institutions, and local law may determine who initially owns particular rights and how they can be assigned. The company must first establish a clean path from each contributor to the appropriate entity and then use intercompany assignments and licenses to place ownership and operating rights where the chosen structure requires them. An intercompany agreement cannot convey rights the transferring entity never acquired.
The Need for Caution When Transferring IP
Transferring IP to a related U.S. company may be treated as a disposal at market value even if no cash is paid. This can crystallize corporation tax, capital gains tax or an exit charge on the IP’s accrued value in the country in which the IP originates, creating a tax liability without corresponding sale proceeds.
As such, you should take advice before completing any steps.
Expansion and a Share-for-Share Flip Do Not Move IP Automatically
Suppose a company was founded outside the United States, developed its initial product there, and later formed a U.S. subsidiary for sales, support or other commercial functions. Unless the foreign company transfers the existing IP, it generally remains where it was. (The same analysis applies where an English company expands into the U.S. or other markets; unless the English parent transfers its IP, it remains with the English parent.) That may be entirely workable: The foreign parent can continue to own the technology while granting the U.S. subsidiary the rights it needs to market, demonstrate, distribute, host or support the product in the United States.
The license or services arrangement should match the business model. An affiliate that merely introduces customers needs different rights from one that signs contracts, grants sublicenses, operates a hosted service or develops integrations. The documents should also allocate rights in material created by the U.S. team. Sales and implementation personnel can generate documentation, integrations, customer-specific developments, data and inventions even when the principal engineers remain abroad.
The same distinction matters in a Delaware flip. In a typical share-for-share transaction, shareholders exchange their interests in the original foreign company for shares of a new Delaware corporation. The transaction changes the ownership hierarchy, but it does not, by itself, transfer the foreign company’s assets. The parties may separately structure an assignment or asset transfer as part of the reorganization, but the IP does not move merely because the original company becomes a subsidiary of the new U.S. parent.
Before selecting an IP model, the company and its advisers should confirm the chain of title and identify licenses, security interests, government funding, R&D incentives, university rights, customer commitments, or other obligations that could limit a transfer or affect its economics.
Three Common Models for Allocating IP Across the Corporate Structure
After confirming chain of title and identifying relevant constraints, the company generally has three approaches to consider:
Each model can work, but the intercompany assignments, licenses, R&D services and related arrangements should reflect the parties’ actual functions and be documented on arm’s-length terms with appropriate tax and transfer-pricing support.
Make Future R&D Follow the Chosen Structure
Selecting the owner of the existing portfolio is only half the work. If a Delaware parent owns or controls the IP while a foreign subsidiary employs the engineers, the company needs a repeatable mechanism for future developments to follow the chosen model. Contributor agreements should be tailored to the law governing each founder, employee and contractor. In some jurisdictions, an individual may be able to assign rights directly to the U.S. parent (or, in a UK structure, to the English parent). In others, the local employer may need to acquire the rights first and then transfer them under the intercompany agreement. Referring generally to an “automatic assignment” can conceal these jurisdiction-specific steps.
The intercompany R&D agreement should connect the local employment structure to the chosen IP structure. It should address background technology, new developments and improvements, the subsidiary’s permitted use, third-party and open-source inputs, invention reporting, filing and enforcement responsibilities, and cooperation when personnel leave. Choice of governing law and jurisdiction for an intercompany IP agreement is also important, including how judgments or awards will be enforced where the relevant IP and assets are located. For example, English law is commonly chosen for its contractual certainty and well-developed case law on IP matters, but mandatory local rules and local filing or recordal requirements may still apply. Confidential know-how should also be supported by practical access controls and disciplined onboarding and offboarding; ownership language alone does not preserve information that is not actually treated as confidential.
The same analysis applies to personnel outside the principal R&D team. If employees of the parent or a sales subsidiary contribute product features, documentation, integrations or inventions, their agreements and the relevant intercompany arrangements should direct those rights to the intended owner. The model should cover how innovation occurs in practice, not merely where management expects it to occur.
What Investors Are Really Testing
Investors are not reviewing IP ownership simply to mark a diligence box. They are testing whether the entity receiving their capital can control the technology on which the investment thesis depends. A clean answer does not always require the Delaware parent to own every asset, but it does require a coherent explanation of who owns the material IP and how the investor-backed company will retain the rights needed to operate and exit. UK venture capital investors, including those investing under the EIS or SEIS regimes, will have particular concerns about core IP ownership sitting in the investee company and about group arrangements that could affect value, control or the availability of relevant tax relief.
Ambiguity creates concern. Investors may accept subsidiary ownership when the parent’s license is sufficiently broad and durable. They are less likely to accept a structure that works only while every affiliate remains under common control and no stress event occurs.
Treat IP Architecture as a Continuing Business Decision
The right home for an international company’s IP may be the U.S. parent, the foreign R&D subsidiary or a carefully structured combination. Whatever model is selected, the company should revisit it when entities add personnel, enter new markets, assume different customer-facing responsibilities, or begin creating or using different technology. Executed agreements, asset schedules, invention records, licenses and required approvals should be maintained as part of ordinary governance rather than assembled for the first time during diligence.
The central objective is to connect ownership, operating access, protection, enforcement and investor control in a structure that can withstand growth and change. When IP is the crown jewel, aligning the corporate and IP architectures is a core business decision, not back-office housekeeping.
Pillsbury’s intellectual property, emerging companies, technology transactions, tax and regulatory lawyers work across jurisdictions to help companies evaluate ownership options, structure intercompany assignments and licenses, and prepare for investor diligence. Early coordination can preserve flexibility and keep the IP strategy aligned with the company the founders are building, not merely the company that exists today.
For many emerging companies, the intellectual property (IP) protecting that innovation is the crown jewel. Yet a parent owns the shares of its subsidiary; it does not thereby own the subsidiary’s assets. Forming a U.S. affiliate, moving personnel or completing a share-for-share flip does not, by itself, transfer technology and related IP from one entity to another. If the corporate and IP structures drift apart, the result can affect valuation, delay a financing, or leave the investor-backed company dependent on rights it does not securely control. However, moving IP between jurisdictions can often result in other issues, such as tax falling due. So what do founders need to be aware of?
The analysis may begin with corporate structure, but it does not end there. The company must align the entities that raise capital, employ the people creating the technology, commercialize it, and own or license the resulting IP. The objective is not to force every international company into the same model. It is to make legal title, operating rights and investor control fit the way the company and its affiliates actually conduct business.
Corporate Structure May Be Planned—or Evolve Organically
When a structure can be planned from the outset, the company can designate the intended IP owner, define the R&D and commercialization roles of each affiliate, and put the necessary assignments and licenses in place before substantial value accumulates. Other structures develop organically. A company may add subsidiaries, move engineers, enter new markets or change which entity contracts with customers. Each change may affect who creates, owns or needs to use the IP. A subsidiary may need a broader license from its parent, a parent may need rights from its subsidiary, or an existing agreement may no longer match the affiliates’ actual roles.
The corporate chart is not a substitute for chain of title. Placing a Delaware parent at the top of the group structure doesn’t make it the owner of IP created by employees of a foreign subsidiary. Those rights must be connected through contributor agreements, assignments, licenses and intercompany arrangements.
As we have previously explained in Startup IP Myths That Can Cost You Millions (or Kill Your Exit), paying a developer does not necessarily mean the company owns the resulting work. The same applies under English law. If the developer is an employee, the invention belongs to the employer where it is made in the course of the employee’s normal duties. Contractors are different: The creator is generally the first owner of relevant rights unless there is an assignment. Founders, employees and contractors may also be subject to obligations owed to former employers, universities or other institutions, and local law may determine who initially owns particular rights and how they can be assigned. The company must first establish a clean path from each contributor to the appropriate entity and then use intercompany assignments and licenses to place ownership and operating rights where the chosen structure requires them. An intercompany agreement cannot convey rights the transferring entity never acquired.
The Need for Caution When Transferring IP
Transferring IP to a related U.S. company may be treated as a disposal at market value even if no cash is paid. This can crystallize corporation tax, capital gains tax or an exit charge on the IP’s accrued value in the country in which the IP originates, creating a tax liability without corresponding sale proceeds.
As such, you should take advice before completing any steps.
Expansion and a Share-for-Share Flip Do Not Move IP Automatically
Suppose a company was founded outside the United States, developed its initial product there, and later formed a U.S. subsidiary for sales, support or other commercial functions. Unless the foreign company transfers the existing IP, it generally remains where it was. (The same analysis applies where an English company expands into the U.S. or other markets; unless the English parent transfers its IP, it remains with the English parent.) That may be entirely workable: The foreign parent can continue to own the technology while granting the U.S. subsidiary the rights it needs to market, demonstrate, distribute, host or support the product in the United States.
The license or services arrangement should match the business model. An affiliate that merely introduces customers needs different rights from one that signs contracts, grants sublicenses, operates a hosted service or develops integrations. The documents should also allocate rights in material created by the U.S. team. Sales and implementation personnel can generate documentation, integrations, customer-specific developments, data and inventions even when the principal engineers remain abroad.
The same distinction matters in a Delaware flip. In a typical share-for-share transaction, shareholders exchange their interests in the original foreign company for shares of a new Delaware corporation. The transaction changes the ownership hierarchy, but it does not, by itself, transfer the foreign company’s assets. The parties may separately structure an assignment or asset transfer as part of the reorganization, but the IP does not move merely because the original company becomes a subsidiary of the new U.S. parent.
Before selecting an IP model, the company and its advisers should confirm the chain of title and identify licenses, security interests, government funding, R&D incentives, university rights, customer commitments, or other obligations that could limit a transfer or affect its economics.
Three Common Models for Allocating IP Across the Corporate Structure
After confirming chain of title and identifying relevant constraints, the company generally has three approaches to consider:
1. Place the IP in the U.S. parent (but beware the tax charges).
Some U.S. investors prefer the Delaware parent to own the core IP because they are investing in that entity. Parent ownership can present a straightforward story for governance, future financings and an eventual sale. If the IP is already held elsewhere, moving it to the parent requires a separate, effective assignment. Before moving a valuable asset across borders, the company and its advisers should evaluate valuation, tax and transfer-pricing consequences, grants and incentives, export restrictions, local approvals, and contractual consent requirements. The foreign R&D subsidiary will also need appropriate rights back from the parent, together with an intercompany R&D agreement addressing its services and ownership of future developments. UK investors similarly prefer the English parent to hold core IP, particularly where EIS or SEIS relief is sought, and the same assignment, tax and transfer-pricing analysis applies.
2. Place or keep the IP in the foreign subsidiary and license the U.S. parent (but beware of transfer pricing).
There may be sound reasons for the foreign subsidiary to own or retain the IP. The foreign subsidiary may own a mature portfolio, conduct the substantive development activity, benefit from local grants or incentives, or face material costs or restrictions on a transfer. In that case, the Delaware parent can receive an exclusive or otherwise appropriately broad license rather than legal title. The critical question is whether the license gives the investor-backed parent durable control of the business it is expected to build, including appropriate rights to sublicense, use future improvements, enforce the IP, and transfer its rights in a financing or sale. Termination, insolvency or a change in control involving the IP-owning affiliate should not leave the parent without the technology on which its business depends. Under English insolvency law (Insolvency Act 1986), an IP licence is generally a contractual right rather than ownership of the underlying IP and may be vulnerable to disclaimer or non-performance by an insolvency officeholder, including a liquidator or administrator; the precise position differs between liquidation and administration. Licensees should consider protective measures such as registration of relevant licences where available, escrow arrangements, and step-in rights.
Also beware of transfer pricing rules which require a license to be on an arm’s length basis. Given the intra-group basis of the IP license, a transfer pricing exercise needs to be undertaken to ensure that any license and associated royalty is commensurate and on arm’s length terms. Your accountant will assist with this exercise (but be aware that the costs are not meager). However, if an authority challenges the arrangement, the receipt of expert advice could help to reduce the risk of reassessment, interest and penalties.
A transfer-pricing exercise does not necessarily mean obtaining a full formal IP valuation every year. It usually means documenting the functional analysis, selecting and supporting a pricing methodology, setting the license terms accordingly, and periodically checking that the outcome remains arm’s length. The license agreement and the parties’ actual conduct must also match; documentation cannot cure an arrangement that is not followed in practice.
3. Divide existing and future IP.
A hybrid model may leave existing or “background” IP with the foreign subsidiary while placing specified future or “foreground” IP in the U.S. parent. This can avoid an immediate transfer of a mature portfolio, but it creates boundary questions when improvements, derivative works or jointly developed features draw on both pools. The agreements should define the dividing line, ownership of improvements, required cross-licenses, and decision rights. Joint ownership should not be used as a convenient placeholder because jurisdictions treat joint owners’ rights differently, potentially complicating licensing, enforcement and an eventual sale.
Some U.S. investors prefer the Delaware parent to own the core IP because they are investing in that entity. Parent ownership can present a straightforward story for governance, future financings and an eventual sale. If the IP is already held elsewhere, moving it to the parent requires a separate, effective assignment. Before moving a valuable asset across borders, the company and its advisers should evaluate valuation, tax and transfer-pricing consequences, grants and incentives, export restrictions, local approvals, and contractual consent requirements. The foreign R&D subsidiary will also need appropriate rights back from the parent, together with an intercompany R&D agreement addressing its services and ownership of future developments. UK investors similarly prefer the English parent to hold core IP, particularly where EIS or SEIS relief is sought, and the same assignment, tax and transfer-pricing analysis applies.
2. Place or keep the IP in the foreign subsidiary and license the U.S. parent (but beware of transfer pricing).
There may be sound reasons for the foreign subsidiary to own or retain the IP. The foreign subsidiary may own a mature portfolio, conduct the substantive development activity, benefit from local grants or incentives, or face material costs or restrictions on a transfer. In that case, the Delaware parent can receive an exclusive or otherwise appropriately broad license rather than legal title. The critical question is whether the license gives the investor-backed parent durable control of the business it is expected to build, including appropriate rights to sublicense, use future improvements, enforce the IP, and transfer its rights in a financing or sale. Termination, insolvency or a change in control involving the IP-owning affiliate should not leave the parent without the technology on which its business depends. Under English insolvency law (Insolvency Act 1986), an IP licence is generally a contractual right rather than ownership of the underlying IP and may be vulnerable to disclaimer or non-performance by an insolvency officeholder, including a liquidator or administrator; the precise position differs between liquidation and administration. Licensees should consider protective measures such as registration of relevant licences where available, escrow arrangements, and step-in rights.
Also beware of transfer pricing rules which require a license to be on an arm’s length basis. Given the intra-group basis of the IP license, a transfer pricing exercise needs to be undertaken to ensure that any license and associated royalty is commensurate and on arm’s length terms. Your accountant will assist with this exercise (but be aware that the costs are not meager). However, if an authority challenges the arrangement, the receipt of expert advice could help to reduce the risk of reassessment, interest and penalties.
A transfer-pricing exercise does not necessarily mean obtaining a full formal IP valuation every year. It usually means documenting the functional analysis, selecting and supporting a pricing methodology, setting the license terms accordingly, and periodically checking that the outcome remains arm’s length. The license agreement and the parties’ actual conduct must also match; documentation cannot cure an arrangement that is not followed in practice.
3. Divide existing and future IP.
A hybrid model may leave existing or “background” IP with the foreign subsidiary while placing specified future or “foreground” IP in the U.S. parent. This can avoid an immediate transfer of a mature portfolio, but it creates boundary questions when improvements, derivative works or jointly developed features draw on both pools. The agreements should define the dividing line, ownership of improvements, required cross-licenses, and decision rights. Joint ownership should not be used as a convenient placeholder because jurisdictions treat joint owners’ rights differently, potentially complicating licensing, enforcement and an eventual sale.
Each model can work, but the intercompany assignments, licenses, R&D services and related arrangements should reflect the parties’ actual functions and be documented on arm’s-length terms with appropriate tax and transfer-pricing support.
Make Future R&D Follow the Chosen Structure
Selecting the owner of the existing portfolio is only half the work. If a Delaware parent owns or controls the IP while a foreign subsidiary employs the engineers, the company needs a repeatable mechanism for future developments to follow the chosen model. Contributor agreements should be tailored to the law governing each founder, employee and contractor. In some jurisdictions, an individual may be able to assign rights directly to the U.S. parent (or, in a UK structure, to the English parent). In others, the local employer may need to acquire the rights first and then transfer them under the intercompany agreement. Referring generally to an “automatic assignment” can conceal these jurisdiction-specific steps.
The intercompany R&D agreement should connect the local employment structure to the chosen IP structure. It should address background technology, new developments and improvements, the subsidiary’s permitted use, third-party and open-source inputs, invention reporting, filing and enforcement responsibilities, and cooperation when personnel leave. Choice of governing law and jurisdiction for an intercompany IP agreement is also important, including how judgments or awards will be enforced where the relevant IP and assets are located. For example, English law is commonly chosen for its contractual certainty and well-developed case law on IP matters, but mandatory local rules and local filing or recordal requirements may still apply. Confidential know-how should also be supported by practical access controls and disciplined onboarding and offboarding; ownership language alone does not preserve information that is not actually treated as confidential.
The same analysis applies to personnel outside the principal R&D team. If employees of the parent or a sales subsidiary contribute product features, documentation, integrations or inventions, their agreements and the relevant intercompany arrangements should direct those rights to the intended owner. The model should cover how innovation occurs in practice, not merely where management expects it to occur.
What Investors Are Really Testing
Investors are not reviewing IP ownership simply to mark a diligence box. They are testing whether the entity receiving their capital can control the technology on which the investment thesis depends. A clean answer does not always require the Delaware parent to own every asset, but it does require a coherent explanation of who owns the material IP and how the investor-backed company will retain the rights needed to operate and exit. UK venture capital investors, including those investing under the EIS or SEIS regimes, will have particular concerns about core IP ownership sitting in the investee company and about group arrangements that could affect value, control or the availability of relevant tax relief.
- Chain of title. Can the company document the path from each relevant contributor to the current owner?
- Scope and continuity. Does the parent own or hold durable rights covering the current product, the credible roadmap and future improvements?
- Commercial control. Can the company use, sublicense, enforce and transfer the technology without an unexpected consent or termination right under the applicable intercompany or third-party arrangements?
- Encumbrances. Are government, university, customer, lender, grant, open-source and joint-development rights understood?
- Tax. Are you inadvertently triggering a tax charge by your structuring?
- Structure in practice. Do the contributor and intercompany agreements match where development and commercialization actually occur?
Ambiguity creates concern. Investors may accept subsidiary ownership when the parent’s license is sufficiently broad and durable. They are less likely to accept a structure that works only while every affiliate remains under common control and no stress event occurs.
Treat IP Architecture as a Continuing Business Decision
The right home for an international company’s IP may be the U.S. parent, the foreign R&D subsidiary or a carefully structured combination. Whatever model is selected, the company should revisit it when entities add personnel, enter new markets, assume different customer-facing responsibilities, or begin creating or using different technology. Executed agreements, asset schedules, invention records, licenses and required approvals should be maintained as part of ordinary governance rather than assembled for the first time during diligence.
The central objective is to connect ownership, operating access, protection, enforcement and investor control in a structure that can withstand growth and change. When IP is the crown jewel, aligning the corporate and IP architectures is a core business decision, not back-office housekeeping.
Pillsbury’s intellectual property, emerging companies, technology transactions, tax and regulatory lawyers work across jurisdictions to help companies evaluate ownership options, structure intercompany assignments and licenses, and prepare for investor diligence. Early coordination can preserve flexibility and keep the IP strategy aligned with the company the founders are building, not merely the company that exists today.